Skip to main content
PMC home page
Mediators of Inflammation logoLink to Mediators of Inflammation
. 1999;8(2):93–100. doi: 10.1080/09629359990586

Estimation of SLE activity based on the serum level of chosen cytokines and superoxide radical generation.

E Waszczykowska 1, E Robak 1, A Wozniacka 1, J Narbutt 1, J D Torzecka 1, A Sysa-Jedrzejowska 1
PMCID: PMC1781789  PMID: 10704146

Abstract

We estimated the serum levels of IL-6, TNF-alpha and IL-10, and generation of superoxide radicals, as well as their mutual dependence, in 63 SLE patients at various stages of disease activity. Our results indicate a statistically significant increase of the serum levels studied, and an increase of superoxide anion generation by granulocytes, in correlation with SLE activity. These results indicate that oxygen metabolism and the examined cytokines play an important role in pathogenesis of SLE. The assessment of these parameters can be useful in the estimation of disease activity.

Full Text

The Full Text of this article is available as a PDF (247.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ara J., Ali R. Reactive oxygen species modified DNA fragments of varying size are the preferred antigen for human anti-DNA autoantibodies. Immunol Lett. 1992 Dec;34(3):195–200. doi: 10.1016/0165-2478(92)90213-8. [DOI] [PubMed] [Google Scholar]
  2. Arai K. I., Lee F., Miyajima A., Miyatake S., Arai N., Yokota T. Cytokines: coordinators of immune and inflammatory responses. Annu Rev Biochem. 1990;59:783–836. doi: 10.1146/annurev.bi.59.070190.004031. [DOI] [PubMed] [Google Scholar]
  3. Aruoma O. I. Nutrition and health aspects of free radicals and antioxidants. Food Chem Toxicol. 1994 Jul;32(7):671–683. doi: 10.1016/0278-6915(94)90011-6. [DOI] [PubMed] [Google Scholar]
  4. Barnes P. J. Reactive oxygen species and airway inflammation. Free Radic Biol Med. 1990;9(3):235–243. doi: 10.1016/0891-5849(90)90034-g. [DOI] [PubMed] [Google Scholar]
  5. Bellavite P., Dri P., Della Bianca V., Serra M. C. The measurement of superoxide anion production by granulocytes In whole blood. A clinical test for the evaluation of phagocyte function and serum opsonic capacity. Eur J Clin Invest. 1983 Aug;13(4):363–368. doi: 10.1111/j.1365-2362.1983.tb00114.x. [DOI] [PubMed] [Google Scholar]
  6. Benke P. J., Levcovitz H., Paupe J., Tozman E. Scavengers of free radical oxygen affect the generation of low molecular weight DNA in stimulated lymphocytes from patients with systemic lupus erythematosus. Metabolism. 1990 Dec;39(12):1278–1284. doi: 10.1016/0026-0495(90)90184-e. [DOI] [PubMed] [Google Scholar]
  7. Brennan D. C., Yui M. A., Wuthrich R. P., Kelley V. E. Tumor necrosis factor and IL-1 in New Zealand Black/White mice. Enhanced gene expression and acceleration of renal injury. J Immunol. 1989 Dec 1;143(11):3470–3475. [PubMed] [Google Scholar]
  8. Emilie D., Llorente L., Galanaud P. Interleukin-10, a key cytokine in inflammatory joint disease. Rev Rhum Engl Ed. 1995 Apr;62(4):229–232. [PubMed] [Google Scholar]
  9. Gabay C., Roux-Lombard P., de Moerloose P., Dayer J. M., Vischer T., Guerne P. A. Absence of correlation between interleukin 6 and C-reactive protein blood levels in systemic lupus erythematosus compared with rheumatoid arthritis. J Rheumatol. 1993 May;20(5):815–821. [PubMed] [Google Scholar]
  10. Handwerger B. S., Rus V., da Silva L., Via C. S. The role of cytokines in the immunopathogenesis of lupus. Springer Semin Immunopathol. 1994;16(2-3):153–180. doi: 10.1007/BF00197515. [DOI] [PubMed] [Google Scholar]
  11. Houssiau F. A., Lefebvre C., Vanden Berghe M., Lambert M., Devogelaer J. P., Renauld J. C. Serum interleukin 10 titers in systemic lupus erythematosus reflect disease activity. Lupus. 1995 Oct;4(5):393–395. doi: 10.1177/096120339500400510. [DOI] [PubMed] [Google Scholar]
  12. Ishida H., Hastings R., Kearney J., Howard M. Continuous anti-interleukin 10 antibody administration depletes mice of Ly-1 B cells but not conventional B cells. J Exp Med. 1992 May 1;175(5):1213–1220. doi: 10.1084/jem.175.5.1213. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Knight J. A. Diseases related to oxygen-derived free radicals. Ann Clin Lab Sci. 1995 Mar-Apr;25(2):111–121. [PubMed] [Google Scholar]
  14. Linker-Israeli M. Cytokine abnormalities in human lupus. Clin Immunol Immunopathol. 1992 Apr;63(1):10–12. doi: 10.1016/0090-1229(92)90084-2. [DOI] [PubMed] [Google Scholar]
  15. Linker-Israeli M., Deans R. J., Wallace D. J., Prehn J., Ozeri-Chen T., Klinenberg J. R. Elevated levels of endogenous IL-6 in systemic lupus erythematosus. A putative role in pathogenesis. J Immunol. 1991 Jul 1;147(1):117–123. [PubMed] [Google Scholar]
  16. Llorente L., Richaud-Patin Y., Couderc J., Alarcon-Segovia D., Ruiz-Soto R., Alcocer-Castillejos N., Alcocer-Varela J., Granados J., Bahena S., Galanaud P. Dysregulation of interleukin-10 production in relatives of patients with systemic lupus erythematosus. Arthritis Rheum. 1997 Aug;40(8):1429–1435. doi: 10.1002/art.1780400810. [DOI] [PubMed] [Google Scholar]
  17. Llorente L., Richaud-Patin Y., Wijdenes J., Alcocer-Varela J., Maillot M. C., Durand-Gasselin I., Fourrier B. M., Galanaud P., Emilie D. Spontaneous production of interleukin-10 by B lymphocytes and monocytes in systemic lupus erythematosus. Eur Cytokine Netw. 1993 Nov-Dec;4(6):421–427. [PubMed] [Google Scholar]
  18. Llorente L., Zou W., Levy Y., Richaud-Patin Y., Wijdenes J., Alcocer-Varela J., Morel-Fourrier B., Brouet J. C., Alarcon-Segovia D., Galanaud P. Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus. J Exp Med. 1995 Mar 1;181(3):839–844. doi: 10.1084/jem.181.3.839. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Malavé I., Searles R. P., Montano J., Williams R. C., Jr Production of tumor necrosis factor/cachectin by peripheral blood mononuclear cells in patients with systemic lupus erythematosus. Int Arch Allergy Appl Immunol. 1989;89(4):355–361. doi: 10.1159/000234975. [DOI] [PubMed] [Google Scholar]
  20. Maury C. P., Teppo A. M. Tumor necrosis factor in the serum of patients with systemic lupus erythematosus. Arthritis Rheum. 1989 Feb;32(2):146–150. doi: 10.1002/anr.1780320206. [DOI] [PubMed] [Google Scholar]
  21. Meijer C., Huysen V., Smeenk R. T., Swaak A. J. Profiles of cytokines (TNF alpha and IL-6) and acute phase proteins (CRP and alpha 1AG) related to the disease course in patients with systemic lupus erythematosus. Lupus. 1993 Dec;2(6):359–365. doi: 10.1177/096120339300200605. [DOI] [PubMed] [Google Scholar]
  22. Mitamura K., Kang H., Tomita Y., Hashimoto H., Sawada S., Horie T. Impaired tumour necrosis factor-alpha (TNF-alpha) production and abnormal B cell response to TNF-alpha in patients with systemic lupus erythematosus (SLE). Clin Exp Immunol. 1991 Sep;85(3):386–391. doi: 10.1111/j.1365-2249.1991.tb05736.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Mosmann T. R. Properties and functions of interleukin-10. Adv Immunol. 1994;56:1–26. [PubMed] [Google Scholar]
  24. Paty J. G., Jr, Sienknecht C. W., Townes A. S., Hanissian A. S., Miller J. B., Masi A. T. Impaired cell-mediated immunity in systemic lupus erythematosus (SLE). A controlled study of 23 untreated patients. Am J Med. 1975 Dec;59(6):769–779. doi: 10.1016/0002-9343(75)90462-3. [DOI] [PubMed] [Google Scholar]
  25. Robak T. Biologia interleukiny 6 (IL-6) i jej znaczenie w patogenezie niektórych chorób. Postepy Hig Med Dosw. 1994;48(5):565–587. [PubMed] [Google Scholar]
  26. Shoenfeld Y., Mozes E. Pathogenic idiotypes of autoantibodies in autoimmunity: lessons from new experimental models of SLE. FASEB J. 1990 Jun;4(9):2646–2651. doi: 10.1096/fasebj.4.9.2140806. [DOI] [PubMed] [Google Scholar]
  27. Snyers L., De Wit L., Content J. Glucocorticoid up-regulation of high-affinity interleukin 6 receptors on human epithelial cells. Proc Natl Acad Sci U S A. 1990 Apr;87(7):2838–2842. doi: 10.1073/pnas.87.7.2838. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Witt C., Neuhaus K., Winsel K., Brenke A., Hiepe F., Volk H. D. Bronchoalveoläre Lavage (BAL) bei Patienten mit systemischer Sklerodermie und systemischem Lupus erythematodes: Charakterisierung der Zellaktivität durch Zytofluorometrie, Chemilumineszenz und Differentialzellbild. Z Erkr Atmungsorgane. 1991;176(1):21–29. [PubMed] [Google Scholar]
  29. al-Janadi M., al-Balla S., al-Dalaan A., Raziuddin S. Cytokine profile in systemic lupus erythematosus, rheumatoid arthritis, and other rheumatic diseases. J Clin Immunol. 1993 Jan;13(1):58–67. doi: 10.1007/BF00920636. [DOI] [PubMed] [Google Scholar]

Articles from Mediators of Inflammation are provided here courtesy of Wiley

RESOURCES